Carme Auladell

4.3k total citations
91 papers, 3.3k citations indexed

About

Carme Auladell is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Carme Auladell has authored 91 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 34 papers in Physiology and 31 papers in Cellular and Molecular Neuroscience. Recurrent topics in Carme Auladell's work include Alzheimer's disease research and treatments (27 papers), Neuroscience and Neuropharmacology Research (25 papers) and Cholinesterase and Neurodegenerative Diseases (12 papers). Carme Auladell is often cited by papers focused on Alzheimer's disease research and treatments (27 papers), Neuroscience and Neuropharmacology Research (25 papers) and Cholinesterase and Neurodegenerative Diseases (12 papers). Carme Auladell collaborates with scholars based in Spain, Mexico and Chile. Carme Auladell's co-authors include Antoni Camins, Jaume Folch, Carlos Beas‐Zárate, Ester Verdaguer, Eduardo Soriano, Miren Ettcheto, Jordi Olloquequi, Mercè Pallàs, José Antonio del Rı́o and Jaume Baguñà and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Development.

In The Last Decade

Carme Auladell

91 papers receiving 3.3k citations

Peers

Carme Auladell
Carme Auladell
Citations per year, relative to Carme Auladell Carme Auladell (= 1×) peers Kazuyuki Takata

Countries citing papers authored by Carme Auladell

Since Specialization
Citations

This map shows the geographic impact of Carme Auladell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carme Auladell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carme Auladell more than expected).

Fields of papers citing papers by Carme Auladell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carme Auladell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carme Auladell. The network helps show where Carme Auladell may publish in the future.

Co-authorship network of co-authors of Carme Auladell

This figure shows the co-authorship network connecting the top 25 collaborators of Carme Auladell. A scholar is included among the top collaborators of Carme Auladell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carme Auladell. Carme Auladell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olloquequi, Jordi, Amanda Cano, Ana Fortuna, et al.. (2025). Licochalcone A prevents cognitive decline in a lipopolysaccharide-induced neuroinflammation mice model. Molecular Medicine. 31(1). 54–54. 3 indexed citations
2.
Cano, Amanda, Elena Sánchez‐López, Ester Verdaguer, et al.. (2025). Colistin treatment causes neuronal loss and cognitive impairment via ros accumulation and neuronal plasticity alterations. Biomedicine & Pharmacotherapy. 183. 117839–117839. 1 indexed citations
3.
Olloquequi, Jordi, Roberto Díaz‐Peña, Ester Verdaguer, et al.. (2024). From Inhalation to Neurodegeneration: Air Pollution as a Modifiable Risk Factor for Alzheimer’s Disease. International Journal of Molecular Sciences. 25(13). 6928–6928. 14 indexed citations
4.
Mirra, Serena, Yasmina Manso, Jaume del Valle, et al.. (2024). A mammalian-specific Alex3/Gα q protein complex regulates mitochondrial trafficking, dendritic complexity, and neuronal survival. Science Signaling. 17(822). eabq1007–eabq1007. 4 indexed citations
5.
Olloquequi, Jordi, Miren Ettcheto, Amanda Cano, et al.. (2023). Licochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment. International Journal of Molecular Sciences. 24(18). 14177–14177. 12 indexed citations
6.
Cano, Amanda, Elena Sánchez‐López, Jordi Olloquequi, et al.. (2023). A novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer’s disease exacerbated with high fat diet. Cell & Bioscience. 13(1). 52–52. 8 indexed citations
7.
Busquets, Oriol, Amanda Cano, Elena Sánchez‐López, et al.. (2022). Peroxisomal Proliferator-Activated Receptor β/δ Deficiency Induces Cognitive Alterations. Frontiers in Pharmacology. 13. 902047–902047. 5 indexed citations
8.
Ettcheto, Miren, et al.. (2020). A Chronological Review of Potential Disease-Modifying Therapeutic Strategies for Alzheimer's Disease. Current Pharmaceutical Design. 26(12). 1286–1299. 11 indexed citations
9.
Auladell, Carme, Rubén D. Castro‐Torres, Oriol Busquets, et al.. (2020). JNK isoforms control mammal adult hippocampal neurogenesis. SHILAP Revista de lepidopterología. 8(16). 5–12. 1 indexed citations
10.
Busquets, Oriol, Miren Ettcheto, Amanda Cano, et al.. (2019). Role of c-Jun N-Terminal Kinases (JNKs) in Epilepsy and Metabolic Cognitive Impairment. International Journal of Molecular Sciences. 21(1). 255–255. 22 indexed citations
11.
Folch, Jaume, Oriol Busquets, Miren Ettcheto, et al.. (2017). Memantine for the Treatment of Dementia: A Review on its Current and Future Applications. Journal of Alzheimer s Disease. 62(3). 1223–1240. 171 indexed citations
12.
Abad, Sònia, Fèlix Junyent, Carme Auladell, et al.. (2014). 3,4-Methylenedioxymethamphetamine enhances kainic acid convulsive susceptibility. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 54. 231–242. 9 indexed citations
13.
Pedrós, Ignacio, Dmitry S. Petrov, Francesc X. Sureda, et al.. (2014). Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(9). 1556–1566. 170 indexed citations
14.
Junyent, Fèlix, Luísa de Lemos, Ester Verdaguer, et al.. (2011). Gene expression profile in JNK3 null mice: a novel specific activation of the PI3K/AKT pathway. Journal of Neurochemistry. 117(2). 244–252. 14 indexed citations
15.
Pizarro‐Delgado, Javier, Jaume Folch, Fèlix Junyent, et al.. (2011). Antiapoptotic effects of roscovitine on camptothecin-induced DNA damage in neuroblastoma cells. APOPTOSIS. 16(5). 536–550. 11 indexed citations
16.
Junyent, Fèlix, Rafael Romero, Luísa de Lemos, et al.. (2009). Taurine treatment inhibits CaMKII activity and modulates the presence of calbindin D28k, calretinin, and parvalbumin in the brain. Journal of Neuroscience Research. 88(1). 136–142. 17 indexed citations
17.
Valente, Tony & Carme Auladell. (2001). Expression pattern of Zac1 mouse gene, a new zinc-finger protein that regulates apoptosis and cellular cycle arrest, in both adult brain and along development. Mechanisms of Development. 108(1-2). 207–211. 49 indexed citations
18.
Auladell, Carme, Albert Martı́nez, Soledad Alcántara, Hans Supèr, & Eduardo Soriano. (1995). Migrating neurons in the developing cerebral cortex of the mouse send callosal axons. Neuroscience. 64(4). 1091–1103. 24 indexed citations
19.
Sánchez, F, F March, N. Cardeñosa, et al.. (1993). Ultrastructural localization of major hydatid fluid antigens in brood capsules and protoscoleces of Echinococcus granulosus of human origin. Parasite Immunology. 15(8). 441–447. 21 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026